Answers are grounded in this paper and cite their sources.
Despite their cardiovascular benefits, SGLT2 inhibitors can be associated with complicated fungal infections including candidemia and patients with anatomical abnormalities of the urogenital tract may be more susceptible to these infections as demonstrated in these cases. Clinicians should be aware of their mechanism of action and associated risk of infection and prior to prescription, assessment of urogenital anatomical abnormalities should be performed to identify patients who may be at risk of complicated infection.
No takes yet. Share an insight, caveat, or question.
Bartolo et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: